Table 3.
Baseline characteristics of participants included in secondary analyses.
| Factors | Total Sample | EPA+DHA Group | Control Group | |
|---|---|---|---|---|
| n/M (%/SE) | n/M (%/SE) | n/M (%/SE) | p-value* | |
| Participants | 32 (100) | 14 (43.8) | 18 (56.2) | 0.48 |
| Age in Years | 61.3 ± 2.1 | 60.8 ± 3.5 | 61.6 ± 2.8 | 0.85 |
| Race | 0.96 | |||
| White | 23 (71.9) | 9 (71.4) | 11 (72.2) | |
| African American | 9 (28.1) | 4 (28.6) | 5 (27.8) | |
| Sex | 0.85 | |||
| Male | 20 (62.5) | 9 (64.3) | 11 (61.1) | |
| Female | 12 (37.5) | 5 (35.7) | 7 (38.9) | |
| Marital Status | 1.00 | |||
| Married/Living w/Someone | 16 (50) | 7 (50) | 9 (50) | |
| Widow/Divorced/Single | 16 (50) | 7 (50) | 9 (50) | |
| Education | 0.58 | |||
| Some High School | 1 (3.1) | 0 (0) | 1 (5.6) | |
| High School Graduate | 10 (31.3) | 5 (35.7) | 5 (27.8) | |
| Some College | 12 (37.5) | 4 (28.6) | 8 (44.4) | |
| College Graduate or > | 9 (28.1) | 5 (35.7) | 4 (22.2) | |
| Employment Status | 0.43 | |||
| Disabled/Unemployed | 28 (87.5) | 13 (92.9) | 15 (83.3) | |
| Employed Part-time | 2 (6.3) | 0 (0) | 2 (11.1) | |
| Employed Full-time | 2 (6.3) | 1 (7.1) | 1 (5.6) | |
| Annual Income | 0.83 | |||
| < $10,000 | 7 (21.9) | 4 (28.6) | 3 (16.7) | |
| $10,000 – $24,999 | 11 (34.4) | 4 (28.6) | 7 (38.9) | |
| $25,000 – $44,999 | 4 (12.5) | 2 (14.2) | 2 (11.1) | |
| > $45,000 | 10 (31.3) | 4 (28.6) | 6 (33.3) | |
| Smoking History | 0.20 | |||
| Current Smoker | 6 (18.8) | 4 (28.6) | 2 (11.1) | |
| Former Smoker | 14 (43.8) | 7 (50) | 7 (38.9) | |
| Never Smoker | 12 (37.5) | 3 (21.4) | 9 (50) | |
| BMI (kg/m2) | 0.64 | |||
| BMI | 41.5 (2.1) | 40.4 (2.1) | 42.4 (3.3) | |
| Comorbidities | ||||
| CVD | 25 (78.1) | 11 (78.6) | 14 (77.8) | 0.96 |
| Diabetes | 16 (50.0) | 9 (64.3) | 7 (38.9) | 0.29 |
| Arthritis | 15 (46.9) | 8 (57.1) | 7 (38.9) | 0.31 |
| Depression | 8 (25) | 3 (21.4) | 5 (27.8) | 0.68 |
EPA = eicosapentaenoic acid; DHA = docosahexaenoic acid; M = mean; SE = standard error; BMI = body mass index; CVD = cardiovascular disease; Meds = medications; L/A = leptin and/or adiponectin.
*
p-value represents the between group comparison.